About Alsonex
Alsonex is a Healthcare company based in Brisbane (Australia) founded in 2014 by Brandon D Lewis and David Groth. It develops new drugs for neurodegenerative diseases through research and partnerships. It operates on a B2B model. Its website alsonex.com.au draws about 681 thousand monthly visits. Alsonex offers products and services including ALS-205. Its focus areas include Biotechnology, Neurodegenerative Diseases, ALS Treatment and Drug Development. Its legal entity is Alsonex Pty Ltd.
Company details
Alsonex is a biopharmaceutical company dedicated to creating innovative treatments for neurodegenerative diseases like Parkinsons, Alzheimers, Huntingtons, and Motor Neuron Disease. Founded in 2014 from research at the University of Queensland, it advances products to proof-of-concept stages and collaborates with larger firms for clinical trials. Based in Brisbane, Australia, the company focuses on drug development while sharing risks to enhance shareholder value through targeted therapies.
- Headquarters Brisbane, Australia
- Founders Brandon D Lewis, David Groth
- SectorsHealthcare
- Email••••••••
- Website alsonex.com.au
- Legal Name Alsonex Pty Ltd
Products & Services of Alsonex
Alsonex offers a comprehensive portfolio of products and services, including ALS-205.
Treatment compound for Motor Neuron Disease and other conditions.
People of Alsonex
2 people are tracked at Alsonex (2 in leadership).
| Name | Role | Group |
|---|---|---|
Brandon D Lewis | Co-Founder | Leadership |
David Groth | Co-Founder | Leadership |
Complete people profiles for Alsonex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of Alsonex
The website of Alsonex (alsonex.com.au) receives about 680.7K visits a month.
- Monthly visits680.7K
▼ 6.7% vs previous month
Websites whose visitors overlap most with Alsonex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| falconebiz.com | 100% | 959.8K | #63,970 | View details | |
| tofler.in | 97% | 556K | #105,509 | View details | |
| zaubacorp.com | 96% | 4.9M | #12,689 | View details | |
| tracxn.com | 92% | 2.9M | #16,597 | View details | |
| indiafilings.com | 90% | 2.1M | #29,959 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Alsonex
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Alsonex
Alsonex was founded in 2014.
Alsonex is headquartered in Brisbane, Australia. It is registered at Brisbane, Queensland, Australia.
Alsonex is a biopharmaceutical company dedicated to creating innovative treatments for neurodegenerative diseases like Parkinsons, Alzheimers, Huntingtons, and Motor Neuron Disease. Founded in 2014 from research at the University of Queensland, it advances products to proof-of-concept stages and collaborates with larger firms for clinical trials. Based in Brisbane, Australia, the company focuses on drug development while sharing risks to enhance shareholder value through targeted therapies.
Alsonex offers ALS-205.
Alsonex operates through Alsonex Pty Ltd.
The website of Alsonex receives about 681 thousand visits a month.